Crossmark

Exploring the mechanisms of cinobufotalin in ovarian cancer treatment: An integrated approach combining network pharmacology, molecular docking and RNA Sequencing

Crossref DOI link: https://doi.org/10.1007/s00210-025-04200-0

Published Online: 2025-04-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mao, Jiajie

Xu, Chen

Hu, Dongsheng

Bao, Huijing
Funding

Funding for this research was provided by:

Tianjin Medical University Nankai hospital grant (81971858-2)
License Information

Text and Data Mining valid from 2025-04-28

Version of Record valid from 2025-04-28
More Information

Article History

Received: 20 March 2025

Accepted: 17 April 2025

First Online: 28 April 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below